Middle-East and Africa Colorectal Cancer Market by Diagnosis (Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy), by Treatment (Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies), and by Region- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Middle-East and Africa Colorectal Cancer Market by Diagnosis (Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy), by Treatment (Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies), and by Region- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 614 | Pages: 138 | October 2016 | Region: Middle East and Africa


The Middle east and Africa Colorectal Cancer Market was worth $0.84 billion in 2016 and estimated to be growing at a CAGR of 2.07%, to reach $0.93 billion by 2021. Though there has been substantial development in science and technology to combat cancer, it continues to threaten lives across the globe.

Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much the cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.

The growth of the Middle east and Africa Colorectal Cancer Market is mainly driven by factors such as rise in aging population, and government policies to provide better care for Colorectal Cancer. However, factors such as high costs of screening tests and poor accessibility of proper health care in this part of the world are hindering the growth of the market.

The Middle east and Africa Colorectal Cancer market is segmented based on Diagnosis and Treatment. The market for Colorectal Cancer, on the basis of Diagnosis is segmented into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy. On the basis of Treatment, the global Colorectal Cancer market is segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.

The market has been geographically segmented into Middle east and Africa. In terms of market share, South Africa leads the market in this region. Other significant markets in this region include Zimbabwe, Zambia, Tanzania and Nigeria. The market in this region has the lowest share due to general lack of awareness.

The major companies dominating the market in this region are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 By Diagnosis                                                               

                                5.1.1 Digital Rectal Examination                                 

                                5.1.2 Faecal Occult Blood Test                                    

                                5.1.3 Flexible Sigmoidoscopy                                     

                                5.1.4 Colonoscopy                                          

                                5.1.5 Virtual Colonoscopy                                            

                5.2 By Treatment                                                            

                                5.2.1 Surgery and Radiation Therapy                                      

                                5.2.2 Chemotherapy                                      

                                5.2.3 Targeted Therapies                                             

                                5.2.4 Resistance to Pharmacological Therapies                                   

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Abbott Diagnostics                                                  

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Alere                                                             

                8.3 Beckman Coulter                                                     

                8.4 Clinical Genomics                                                     

                8.5 Companion Dx                                                          

                8.6 Hoffmann La Roche                                                

                8.7 Debiopharm Group                                                 

                8.8 Vaccinogen BD                                                          

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Colorectal Cancer Market By Region, From 2016-2021 (USD Billion)
  2. Middle East & Africa Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  3. Middle East & Africa Digital Rectal Examination Market By Region, From 2016-2021 (USD Billion)
  4. Middle East & Africa Faecal Occult Blood Test Market By Region, From 2016-2021 (USD Billion)
  5. Middle East & Africa Flexible Sigmoidoscopy Market By Region, From 2016-2021 (USD Billion)
  6. Middle East & Africa Colonoscopy Market By Region, From 2016-2021 (USD Billion)
  7. Middle East & Africa Virtual Colonoscopy Market By Region, From 2016-2021 (USD Billion)
  8. Middle East & Africa Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  9. Middle East & Africa Surgery and Radiation Therapy Market By Region, From 2016-2021 (USD Billion)
  10. Middle East & Africa Chemotherapy Market By Region, From 2016-2021 (USD Billion)
  11. Middle East & Africa Targeted Therapies Market By Region, From 2016-2021 (USD Billion)
  12. Middle East & Africa Resistance to Pharmacological Therapies Market By Region, From 2016-2021 (USD Billion)
  13. Middle East Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  14. Middle East Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
  15. Africa Colorectal Cancer Market By Diagnosis, From 2016-2021 (USD Billion)
  16. Africa Colorectal Cancer Market By Treatment , From 2016-2021 (USD Billion)
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...
Middle East and Africa Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Ret...
Latin America Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharm...
Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharma...
Europe Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by end user (Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies....
North America Market Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user (Hospital, Oncology centers, Hospital Pharmacies and Reta...
Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.